HFE Genotype in
Patients with Hemochromatosis and other Liver Diseases with Iron Overload in the Czech Republic
Půtová I.1, ČimburováM.2, Cieslarová B.3, Pučelíková T.3, Stránský J.3, Horák J.3
Centrum biomedicínských oborů, oddělení buněčné a molekulární biologie, 3. LF UK, Praha Centrum preventivního lékařství, oddělení zdraví dětí a mládeže, 3. LF UK, Praha I. interní klinika FNKV a 3. LF UK, Praha |
|
Summary:
Hereditary hemochromatosis is one of the most common autosomal recessive diseases. As a result of inappropriately
high iron absorption by the small intestine iron accumulates in parenchymatous organs thus causing
their damage.
Aim of the study: To establish frequency of C282Y and H63D mutations in the HFE gene (the hemochromatosis
gene) in general population of the Czech Republic and in defined patient groups and to find out whether
hemochromatosis in homo- or heterozygous state plays a role in the pathogenesis of other liver diseases.
Patients and Methods: In 122 patients (59 males and 63 females, average age 42.3 years) with chronic
hepatitis C (n = 23), alcoholic liver cirhosis (n = 19), both alcoholic and non-alcoholic steatohepatitis (n = 20),
etiologically unclear liver disease (n = 41) and in a control group (n = 257) the presence of HFE gene
mutations was etablished. Genomic DNA was amplified by a PCR. The amplified product was digested by
restriction endonucleases RsaI or BclI. The digested product was then electrophoretically analysed on agarose
gel. Results. Homozygous C282Y or H63D mutation was found in 74% of patients with hemochromatosis.
Heterozygous H63D mutation was found in 25% of patients with steatohepatitis and in 16% of patients with
alcoholic liver cirrhosis. In the group of etiologically unclear liver disease, 10% homozygotes for C282Y, 5% for
H63D and 7.3% heterozygotes H63D and 2.4% C282Y were identified, respectively. In the control group, 7.8%
carriers of mutation C282Y and 26.8% of H63D were found. Conclusions: Results of this study show that
homo- or heterozygosity for either mutation may play a role in pathogenesis of other liver diseases apart from
hemochromatosis such as chronic hepatitis C, alcoholic liver cirrhosis or cryptogenic chronic liver disease.
Key words:
|